Get my drift?
Back in 2008, an excited Pfizer shelled out $40 million upfront and agreed to make a $10 million equity investment in exchange for the worldwide rights to Celldex's CDX-110 (rindopepimut), a promising brain cancer vaccine. But by last September, that therapy no longer fit into Pfizer's new vision of its future, and the Big Pharma company washed its hands of its $440 million deal for the program.
Get my drift?Back in 2008, an excited Pfizer shelled out $40...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.21 |
Change
-0.270(1.74%) |
Mkt cap ! $1.947B | |||
| Open | High | Low | Value | Volume |
| $15.20 | $15.33 | $15.02 | $8.268M | 543.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 700 | $15.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.24 | 220 | 1 |
View Market Depth
| Last trade - 16.10pm 22/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |